EPTIS
BAM Logo

Measurable Residual Disease for ALL by Flow Cytometry

EPTIS factsheet 146101 | Last revision 2022-02-11 | URL: https://www.eptis.bam.de/pts146101 https://www.eptis.bam.de/pts146101

PT provider
PT provider UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping
Based in United Kingdom
Language(s)
Remarks Further information may be found at http://www.ukneqasli.co.uk/eqa-pt-programmes/flow-cytometry-programmes/measurable-residual-disease-for-all-by-flow-cytometry-accredited/
Keywords
Product groups Human test material
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Stabilised whole blood % of residual leukaemic cells Flow cytometry
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards ISO17043:2010, ISO15189:2012, ISO 13528:2015
Additional, subsidiary aims characterisation of reference materials and validation of testing methods
Number of participants 140
Accredited or otherwise reviewed by a 3rd party

Accredited by UKAS on the basis of ISO/IEC 17043

Operation is commissioned / requested by
Fees and frequency
Participation fee Please contact UKNEQASLI for details
Regularly operated Yes (4 per annum)
Year of first operation 2010
Contact details of the PT provider
Provider Contact person
UK NEQAS for Leucocyte Immunophenotyping
4th Floor, Pegasus House, 463a Glossop Road
S10 2QD Sheffield
United Kingdom

Phone: +44 (0) 114 2673600
Fax:
Web: http://www.ukneqasli.co.uk http://www.ukneqasli.co.uk
Mr Matthew Fletcher
Phone: +44 (0) 114 2673600
Fax:
Email: admin@ukneqasli.co.uk admin@ukneqasli.co.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5